Energy Transfer and Sunoco Donate $2 Million to MD Anderson for Pediatric Cancer Research
- Energy Transfer and Sunoco employees donated $2 million to MD Anderson Cancer Center through their 2024 workplace giving campaign, supporting pediatric cancer research.
- Since 2014, Energy Transfer and Sunoco employees have donated over $17 million to MD Anderson, funding clinical trials and research initiatives.
- The funds will support pediatric cancer research at MD Anderson Children’s Cancer Hospital, advancing treatment options for young patients.
- MD Anderson representatives visited Energy Transfer's headquarters to share research breakthroughs made possible by the donations, including menin inhibitor research.
Energy Transfer and Sunoco have donated $2 million to The University of Texas MD Anderson Cancer Center to support pediatric cancer research. The donation comes as a result of Energy Transfer's 2024 workplace giving campaign, which included contributions from over 1,200 Energy Transfer and Sunoco employees across the country and corporate matching funds.
Richard Gorlick, M.D., division head and chair of Pediatrics at MD Anderson, stated, "The generous contributions from more than 1,200 Energy Transfer and Sunoco employees across the country is truly remarkable. Through the dedicated support of these committed employees, we can fund important clinical trials that make a significant difference in the lives of pediatric cancer patients now and in the future."
Since 2014, Energy Transfer and Sunoco employees have donated more than $17 million to MD Anderson through their annual fundraising efforts. The annual campaign includes contributions from corporate funds and more than $1 million from the Energy Transfer/Sunoco Foundation. All funds will support pediatric cancer research at MD Anderson Children’s Cancer Hospital.
Chris Curia, chief human resources officer for Energy Transfer, said, "Energy Transfer and Sunoco employees are proud to continue their support of MD Anderson and its mission to eliminate cancer through their exceptional research and treatment efforts. We continue to be inspired by the truly remarkable advances their research is bringing to the treatment of pediatric cancers and the differences being made in the lives of children and their families."
In October, representatives from MD Anderson Children’s Cancer Hospital visited Energy Transfer’s headquarters in Dallas, Texas, to meet with senior leaders. Gorlick shared research breakthroughs made possible through Energy Transfer’s support, including menin inhibitor research, which is particularly impactful for pediatric patients facing leukemia and other blood diseases.

Stay Updated with Our Daily Newsletter
Get the latest pharmaceutical insights, research highlights, and industry updates delivered to your inbox every day.
Related Topics
Reference News
[1]
Energy Transfer and Sunoco donate $2 million to support pediatric cancer research at MD Anderson
mdanderson.org · Nov 23, 2024
Energy Transfer donates $2 million to MD Anderson Cancer Center's pediatric cancer research, bringing total employee con...